Dosage & Administration Drug label Financial assistance

Delstrigo

(doravirine / lamivudine / tenofovir disoproxil)

Delstrigo 100 MG / 300 MG / 300 MG Oral Tablet

Dosage & administration

* Testing: Prior to or when initiating DELSTRIGO, test for HBV infection. Prior to or when initiating DELSTRIGO, and during treatment with DELSTRIGO, on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus.
* Recommended dosage: One tablet taken orally once daily with or without food in adults and pediatric patients weighing at least 35 kg.
* Renal impairment: Not recommended in patients with estimated creatinine clearance below 50 mL per minute.
* Dosage adjustment with rifabutin: Take one tablet of DELSTRIGO once daily, followed by one tablet of doravirine 100 mg (PIFELTRO) approximately 12 hours after the dose of DELSTRIGO.

drug label

Delstrigo prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Delstrigo financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

patient education

Delstrigo patient education

Getting started on Delstrigo

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

BRAND PAGEAbout Delstrigo

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGESide Effects

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERView How to Take Delstrigo

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFPatient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Other resources

Learn More

Delstrigo FAQs

How is the dosage of Delstrigo?Delstrigo is available in 1 dosages, including 100-300-300 mg Tab

What does Delstrigo treat?Delstrigo treats Acquired Immunodeficiency Syndrome and Chronic Hepatitis B

What is Delstrigo made of?Delstrigo contains doravirine / lamivudine / tenofovir disoproxil which is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

How Is Delstrigo Administered?Delstrigo is administered as a Oral Pill

What Are The Delstrigo Mechanism Of Action?Delstrigo mechanism of action is Non-Nucleoside Reverse Transcriptase Inhibitors or Nucleoside Reverse Transcriptase Inhibitors

FAQ Data Source

Delstrigo

Dosage & administration

drug label

Delstrigo prescribing information

financial assistance

Delstrigo financial assistance options

Co-pay savings program

patient education

Delstrigo patient education

Getting started on Delstrigo

Patient toolkit

Other resources

people also ask

Delstrigo FAQs